FDA Issues Boxed Warning for Febuxostat & Approves Colchicine for Gout Flare
FDA Expands Safety Measures for Immediate Release Opioids
EU Grants Marketing Authorization for Hyrimoz; Plus FDA Rejects New Drug Application for Buprenorphine Sublingual Spray
FDA Receives Reports of Loperamide Abuse
Rheumatology Drug Updates: Hip Fracture Rates After Bisphosphonate Drug Holidays, Plus More on Golimumab, Ustekinumab
Limbrel Linked to Possible Fatal Adverse Events
Rheumatology Drug Updates: Efficacy Studied Following Accelerated Drug Approvals; Plus Secukinumab Meets Benchmark for Psoriasis
Rheumatology Drug Updates: Biosiomilar to Adalimumab Receives FDA Approval; plus Updates on Baricitinib, Tofacitinib, Bimekizumab
Report on EU’s Experience with Biosimilar Drugs Released: Will U.S. Experience Be Similar?
- 1
- 2
- 3
- …
- 13
- Next Page »